These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30210045)

  • 1. Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?
    Marinko T; Stanic K
    Radiol Oncol; 2018 Mar; 52(3):275-280. PubMed ID: 30210045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
    Asaga S; Kinoshita T; Shiino S; Jimbo K; Takayama S
    Breast J; 2019 Jan; 25(1):26-33. PubMed ID: 30414218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
    Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I
    Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
    Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
    Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram.
    Wadasadawala T; Kannan S; Gudi S; Rishi A; Budrukkar A; Parmar V; Shet T; Desai S; Gupta S; Badwe R; Sarin R
    Indian J Cancer; 2017; 54(1):352-357. PubMed ID: 29199721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
    Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
    [No Abstract]   [Full Text] [Related]  

  • 13. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy.
    Dunst J; Steil B; Furch S; Fach A; Lautenschläger C; Diestelhorst A; Lampe D; Kölbl H; Richter C
    Strahlenther Onkol; 2001 Oct; 177(10):504-10. PubMed ID: 11680014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
    Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
    Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
    J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer.
    Lee JC; Truong PT; Kader HA; Speers CH; Olivotto IA
    Clin Oncol (R Coll Radiol); 2005 Dec; 17(8):623-9. PubMed ID: 16372488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
    Tan CF; Wang J; Zhong XR; Dai ZL; Xiang ZZ; Zeng YY; Wei XY; Xu NY; Liu L
    Breast Cancer Res Treat; 2024 Jul; 206(1):45-56. PubMed ID: 38616207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
    Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.